rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2006-5-15
|
pubmed:abstractText |
Hepatosplenic gamma-delta T-cell lymphoma is a rare, usually fatal lymphoma and available literature on management is sparse. Allografting is probably the only curative option. We describe a further case with a dramatic, though transient response to Fludarabine and Alemtuzumab combination, following a failure of conventional chemotherapy. Given the dreadful prognosis with conventional chemotherapy, it is a regimen worth pursuing as a disease reduction strategy prior to allograft where appropriate.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Cytarabine,
http://linkedlifedata.com/resource/pubmed/chemical/Epirubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Etoposide,
http://linkedlifedata.com/resource/pubmed/chemical/Ifosfamide,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Methylprednisolone,
http://linkedlifedata.com/resource/pubmed/chemical/Pentostatin,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Antigen, T-Cell...,
http://linkedlifedata.com/resource/pubmed/chemical/Vidarabine,
http://linkedlifedata.com/resource/pubmed/chemical/alemtuzumab,
http://linkedlifedata.com/resource/pubmed/chemical/fludarabine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0902-4441
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
76
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
531-4
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:16548918-Adolescent,
pubmed-meshheading:16548918-Antibodies, Monoclonal,
pubmed-meshheading:16548918-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:16548918-Antibodies, Neoplasm,
pubmed-meshheading:16548918-Antimetabolites, Antineoplastic,
pubmed-meshheading:16548918-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16548918-Cisplatin,
pubmed-meshheading:16548918-Combined Modality Therapy,
pubmed-meshheading:16548918-Crohn Disease,
pubmed-meshheading:16548918-Cytarabine,
pubmed-meshheading:16548918-Epirubicin,
pubmed-meshheading:16548918-Epstein-Barr Virus Infections,
pubmed-meshheading:16548918-Etoposide,
pubmed-meshheading:16548918-Fatal Outcome,
pubmed-meshheading:16548918-Gene Rearrangement, delta-Chain T-Cell Antigen Receptor,
pubmed-meshheading:16548918-Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor,
pubmed-meshheading:16548918-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:16548918-Humans,
pubmed-meshheading:16548918-Ifosfamide,
pubmed-meshheading:16548918-Immunosuppressive Agents,
pubmed-meshheading:16548918-Liver,
pubmed-meshheading:16548918-Lymphoma, T-Cell, Peripheral,
pubmed-meshheading:16548918-Lymphoproliferative Disorders,
pubmed-meshheading:16548918-Male,
pubmed-meshheading:16548918-Methylprednisolone,
pubmed-meshheading:16548918-Pentostatin,
pubmed-meshheading:16548918-Receptors, Antigen, T-Cell, gamma-delta,
pubmed-meshheading:16548918-Remission Induction,
pubmed-meshheading:16548918-Spleen,
pubmed-meshheading:16548918-Transplantation, Homologous,
pubmed-meshheading:16548918-Vidarabine
|
pubmed:year |
2006
|
pubmed:articleTitle |
A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab.
|
pubmed:affiliation |
Department of Clinical Haematology, Aberdeen Royal Infirmary, Aberdeen, UK. sajjanmittal@yahoo.com
|
pubmed:publicationType |
Journal Article,
Case Reports
|